Survey of Ophthalmology
Volume 55, Issue 5 , Pages 467-480 , September 2010

Forget Me Not

  • Behin Barahimi, MD

      Affiliations

    • Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    • ,
  • Ann P. Murchison, MD, MPH

      Affiliations

    • Oculoplastic and Orbital Surgery Service, Wills Eye Institute, Philadelphia, Pennsylvania, USA
    • Corresponding Author InformationReprint address: Ann P. Murchison, MD, MPH, Wills Eye Institute, 840 Walnut St., Suite 910, Philadelphia, PA 19107.
    • ,
  • Jurij R. Bilyk, MD

      Affiliations

    • Oculoplastic and Orbital Surgery Service, Wills Eye Institute, Philadelphia, Pennsylvania, USA

References 

  1. Ali SM, Ahmed SH. Cavernous sinus thrombosis in children. J Trop Pediatr. 1992;38:194–195
  2. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10:87–111
  3. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA. 2009;301:2362–2375
  4. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for treating severe sepsis and septic shock. Cochrane Database of Systematic Reviews. 2004;(1):CD002243
  5. Austin H, Key NS, Benson JM, et al. Sickle cell trait and the risk of venous thromboembolism among blacks. Blood. 2007;110:908–912
  6. Bhatia K, Jones NS. Septic cavernous sinus thrombosis secondary to sinusitis: are anticoagulants indicated? A review of the literature. J Laryngol Otol. 2002;116:667–676
  7. Bousser MG. Aspirin or heparin immediately after a stroke?. Lancet. 1997;349:1564–1565
  8. Browder J, Kaplan HA. Cerebral Dural Sinuses and Their Tributaries. Springfield, IL: Thomas; 1976;p 120
  9. Cheung N, McNab AA. Venous anatomy of the orbit. Invest Ophthalmol Vis Sc. 2003;44:988–995
  10. Chiller K, Selkin B, Murakawa G. Skin microflora and bacterial infections of the skin. J Inves Dermatol Symp P. 2001;6:170–174
  11. Connor SJ, Grimm MC. Heparin as an anti-inflammatory agent: its no GAG to forget about chemokines. Gut. 2001;48:738
  12. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry. 2001;70:105–108
  13. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484–488
  14. Diaz JM, Schiffman JS, Urban ES, et al. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand. 1992;86:390–396
  15. Dolan RW, Chowdhury K. Diagnosis and treatment of intracranial complications of paranasal sinus infections. J Oral Maxillofac Surg. 1995;53:1080–1087
  16. Dutton JJ. Atlas of Clinical and Surgical Orbital Anatomy. Philadelphia, PA: Saunders; 1994;p 240
  17. Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597–600
  18. Evans HW. Cavernous sinus thrombosis. J Lancet. 1965;85:109–113
  19. Ferro JM, Correia M, Pontes C, et al. Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Cerebral vein and dural sinus thrombosis in Portugal: 1980–1998. Cerebrovasc Dis. 2001;11:177–182
  20. Gallagher RM, Gross CW, Phillips CD. Suppurative intracranial complications of sinusitis. Laryngoscope. 1998;108:1635–1642
  21. Garth RJ, Brightwell AP. A comparison of packing materials used in nasal surgery. J Laryngol Otol. 1994;108:564–566
  22. Gettelfinger DM, Kokmen E. Superior sagittal sinus thrombosis. Arch Neurol. 1977;34:2–6
  23. Goldberg RA, Rootman J, Cline RA. Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol. 1990;35:1–24
  24. Grossman RI, Yousem DM. The Requisites: Neuroradiology. 2nd ed.. Philadelphia: Mosby; 2003;pp 1–24, 89–93
  25. Harris GJ. Subperiosteal abscess of the orbit. Arch Ophthalmol. 1983;101:751–775
  26. Holds JB. Commentary on effect of corticosteroids in the acute management of pediatric orbital cellulitis with subperiosteal abscess. Ophthal Plast Reconstr Surg. 2005;21:366–367
  27. Igarashi H, Igarashi S, Fujio N, et al. Magnetic resonance imaging in the early diagnosis of cavernous sinus thrombosis. Ophthalmologica. 1995;209:292–296
  28. Jamal BT, Diecidue RJ, Taub D, et al. Orbital hemorrhage and compressive optic neuropathy in patients with midfacial fractures receiving low-molecular weight heparin therapy. J Oral Maxillofac Surg. 2009;67:1416–1419
  29. Karlin RJ, Robinson WA. Septic cavernous sinus thrombosis. Ann Emerg Med. 1984;13:449–455
  30. Kloek CE, Rubin PA. Role of inflammation in orbital cellulitis. Int Ophthalmol Clin. 2006;46:57–68
  31. In:  Kretschmann HJ,  Weinrich W editor. Cranial Neuroimaging and Clinical Neuroanatomy: Magnetic Resonance Imaging and Computed Tomography. ed 2. New York: Thieme; 1993;
  32. Lane KA, Bilyk JR. Current concepts in the diagnosis and management of idiopathic orbital inflammation, in: Guthoff R, Katowitz J, eds. Essentials in Ophthalmology: Oculoplastics and Orbit. Berlin, Springer Verlag, in press
  33. Levine SR, Langer SL, Albers JW, et al. Sneddons syndrome: an antiphospholipid antibody syndrome?. Neurology. 1988;38:798–800
  34. Maiti B, Chakrabarti I. Study on cerebral venous sinus thrombosis with special reference to efficacy of heparin. J Neurol Sci. 1997;150(Supplement 1):s147
  35. In:  Mandell GL,  Bennett JE,  Dolin R editor. Principles and Practice of Infectious Disease. Philadelphia: Elsevier Churchill Livingstone; 2005;ed 6
  36. Masuhr F, Mehraein S. Cerebral venous and sinus thrombosis: patients with a fatal outcome during intravenous dose-adjusted heparin treatment. Neurocrit Care. 2004;1:355–361
  37. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674
  38. Nagaraja D, Rao BSS, Taly AB, et al. Randomized controlled trial of heparin in puerperal cerebral venous/sinus thrombosis. NIMHANS J. 1995;13:111–115
  39. Naimi TS, LeDell KH, Boxrud DJ, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996–1998. Clin Infect Dis. 2001;33:990–996
  40. Pavlovich P, Looi A, Rootman J. Septic thrombosis of the cavernous sinus: two different mechanisms. Orbit. 2006;25:39–43
  41. Rebsamen SL, Bilaniuk LT, Granet D, et al. Orbital wall infarction in sickle cell disease: MR evaluation. AJNR Am J Neuroradiol. 1993;14:777–779
  42. In:  Roos KL editors. Principles of Neurologic Infectious Diseases. New York: McGraw–Hill; 2005;
  43. Sahjpaul RL, Lee DH. Infratentorial subdural empyema, pituitary abscess, and septic cavernous sinus thrombophlebitis secondary to paranasal sinusitis: case report. Neurosurgery. 1999;44:864–866
  44. Schuknecht B, Simmen D, Yuksel C, et al. Tributary venosinus occlusion and septic cavernous sinus thrombosis: CT and MR findings. AJNR Am J Neuro-radiol. 1998;19:617–626
  45. Shaw RE. Cavernous sinus thrombophlebitis: a review. Br J Surg. 1952;40:40–48
  46. Sligl WI, Milner DA, Sundar S, et al. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta–analysis. Clin Infect Dis. 2009;49:93–101
  47. Solomon OD, Moses L, Volk M. Steroid therapy in cavernous sinus thrombosis. Am J Ophthalmol. 1962;54:1122–1124
  48. Southwick FS, Richardson EP, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore). 1986;65:82–106
  49. Stam J, de Bruijn SSFTM, deVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database of Systematic Reviews. 2009;3
  50. Tsaras G, Owusu-Ansah A, Boateng FO, et al. Complications associated with sickle cell trait: a brief narrative review. Am J Med. 2009;122:507–512
  51. van den Belt AG, Hutten BA, Prins MH, et al. Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S––a decision analysis. Thromb Haemost. 2000;84:758–763
  52. Weber AL, Mikulis DK. Inflammatory disorders of the paraorbital sinuses and their complications. Radiol Clin North Am. 1987;25:615–630
  53. Yen MT, Yen KG. Effect of corticosteroids in the acute management of pediatric orbital cellulitis with subperiosteal abscess. Ophthal Plast Reconstr Surg. 2005;21(5):363–366
  54. Youssef OH, Stefanyszyn MA, Bilyk JR. Odontogenic orbital cellulitis. Ophthal Plast Reconstr Surg. 2008;24:29–35

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(09)00312-9

doi: 10.1016/j.survophthal.2009.12.001

Survey of Ophthalmology
Volume 55, Issue 5 , Pages 467-480 , September 2010

Article Tools

* Image Usage & Resolution